Pancreatic beta-cell function and fetal growth in gestational impaired glucose tolerance

Acta Obstet Gynecol Scand. 2010 Jun;89(6):769-75. doi: 10.3109/00016349.2010.487091.

Abstract

Objective: To investigate the metabolic phenotype and pregnancy outcomes of gestational impaired glucose tolerance (IGT) defined by isolated hyperglycemia during an oral glucose tolerance test (OGTT).

Design: Retrospective cohort study.

Setting: University referral hospital.

Population: A total of 4,789 women were screened for gestational diabetes mellitus (GDM) between 1996 and 2008 with a glucose challenge test (GCT), followed by a 2-hour 75-g OGTT if the GCT result was abnormal; in addition, measurement of plasma insulin concentration during the OGTT was implemented from 2004.

Methods: The insulin sensitivity (IS(OGTT)) and beta-cell function (insulinogenic index/homeostasis model assessment for insulin resistance) were calculated for 283 women who underwent a diagnostic OGTT between 2004 and 2008. Perinatal complications were examined in 4,789 women who were screened for GDM between 1996 and 2008.

Main outcome measures: Comparison of outcomes among women stratified by glucose tolerance status using the GCT and OGTT profiles.

Results: Insulin sensitivity and beta-cell function significantly decreased from normal OGTT to 2-hour IGT (single hyperglycemia at 2 hours) to 1-hour IGT (single hyperglycemia at 1 hour) to GDM, with significant differences between normal OGTT and 1-hour IGT or GDM. The occurrence of large-for-gestational age (LGA) neonates was significantly increased in women with GDM or 1-hour IGT (adjusted odds ratio: 2.15, 2.22; 95% confidence interval 1.23-3.75 and 1.04-4.35, respectively) compared to those with normal GCT or normal diagnostic OGTT results.

Conclusions: Like GDM, isolated 1-hour hyperglycemia on the OGTT is associated with beta-cell dysfunction and an increased risk for LGA neonates.

MeSH terms

  • Adult
  • Asian People
  • Blood Glucose / analysis
  • Diabetes, Gestational / blood
  • Diabetes, Gestational / diagnosis
  • Diabetes, Gestational / metabolism*
  • Female
  • Fetal Development / physiology*
  • Fetal Macrosomia / metabolism
  • Glucose Intolerance / blood
  • Glucose Intolerance / diagnosis
  • Glucose Intolerance / metabolism*
  • Glucose Tolerance Test
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / metabolism*
  • Infant, Newborn
  • Insulin-Secreting Cells / metabolism*
  • Pregnancy
  • Pregnancy Complications / blood
  • Pregnancy Complications / diagnosis
  • Pregnancy Complications / metabolism
  • Pregnancy Outcome
  • Retrospective Studies

Substances

  • Blood Glucose